We are live on ! Find out more
DPA

Devon Park Associates Portfolio holdings

AUM $30.8M
1-Year Est. Return 0.85%
This Fund
S&P 500
This Quarter Est. Return
+20.91%
1 Year Est. Return
+0.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$15.1M
Cap. Flow
-$9.78M
Cap. Flow %
-6.48%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TVRD
Tvardi Therapeutics
TVRD
+$5.99M
2
TARA icon
Protara Therapeutics
TARA
+$3.79M

Sector Composition

Rank Sector Weight
1 Healthcare 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZSPH
1
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$135M 89.47%
2,576,723
– –
RCKT icon
2
Rocket Pharmaceuticals
RCKT
$340M
$15.9M 10.53%
810,927
– –
TARA icon
3
Protara Therapeutics
TARA
$220M
– –
-8,143
Closed -$3.79M
TVRD
4
Tvardi Therapeutics
TVRD
$19.7M
– –
-16,558
Closed -$5.99M

Similar funds

DMS
Discretionary Management Services Merriam, Kansas $29.4M AUM 8.62% 1-Year Est. Return
SCM
Sabal Capital Management Santa Monica, California $33.2M AUM 0.1% 1-Year Est. Return
NCA
NCM Capital Advisers Durham, North Carolina $33.6M AUM 9.49% 1-Year Est. Return
EDRPMB
Edmond de Rothschild Private Merchant Banking London, United Kingdom $27.2M AUM 28.43% 1-Year Est. Return
HSS
Harrison Street Securities Chicago, Illinois $34.4M AUM 20.42% 1-Year Est. Return
LOCC
Lombard Odier & Cie (Canada) Montreal, Quebec, Canada $35.1M AUM 13.46% 1-Year Est. Return
BSCM
Baker Street Capital Management Los Angeles, California $35.2M AUM 75.02% 1-Year Est. Return
GPI
Georgian Partners I Toronto, Ontario, Canada $25.3M AUM 21.88% 1-Year Est. Return

Devon Park Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Devon Park Associates held 4 positions worth $151M, up 11% from $136M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Devon Park Associates withdrew a net $9.78M in Q2 2015, closing 2 positions. Its most notable exit was Tvardi Therapeutics, an estimated $5.99M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 20% a quarter earlier.

  • Devon Park Associates fully exited Tvardi Therapeutics in Q2 2015, selling an estimated $5.99M.
  • Devon Park Associates's ten largest holdings make up 100% of its $151M portfolio in Q2 2015.
  • Devon Park Associates opened 0 new positions and closed 2 in Q2 2015.
  • Devon Park Associates's portfolio value rose 11% quarter-over-quarter to $151M.

Based on Devon Park Associates's 13F filing for Q2 2015, filed 14 Aug 2015.